The Influence of Short Motifs on the Anticancer Activity of HB43 Peptide

Despite the remarkable similarity in amino acid composition, many anticancer peptides (ACPs) display significant differences in terms of activity. This strongly suggests that particular relative dispositions of amino acids (motifs) play a role in the interaction with their biological target, which is often the cell membrane. To better verify this hypothesis, we intentionally modify HB43, an ACP active against a wide variety of cancers. Sequence alignment of related ACPs by ADAPTABLE web server highlighted the conserved motifs that could be at the origin of the activity. In this study, we show that changing the order of amino acids in such motifs results in a significant loss of activity against colon and breast cancer cell lines. On the contrary, amino acid substitution in key motifs may reinforce or weaken the activity, even when the alteration does not perturb the amphipathicity of the helix formed by HB43 on liposomes mimicking their surface. NMR and MD simulations with different membrane models (micelles, bicelles, and vesicles) indicate that the activity reflects the insertion capability in cancer-mimicking serine-exposing membranes, supported by the insertion of N-terminal phenylalanine in the FAK motif and the anchoring to the carboxylate of phosphatidylserine by means of arginine side chains.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:14

Enthalten in:

Pharmaceutics - 14(2022), 5 vom: 19. Mai

Sprache:

Englisch

Beteiligte Personen:

Herrera-León, Claudia [VerfasserIn]
Ramos-Martín, Francisco [VerfasserIn]
El Btaouri, Hassan [VerfasserIn]
Antonietti, Viviane [VerfasserIn]
Sonnet, Pascal [VerfasserIn]
Martiny, Laurent [VerfasserIn]
Zevolini, Fabrizia [VerfasserIn]
Falciani, Chiara [VerfasserIn]
Sarazin, Catherine [VerfasserIn]
D'Amelio, Nicola [VerfasserIn]

Links:

Volltext

Themen:

Anticancer
Antimicrobial
Biomembranes
Journal Article
Molecular dynamics
NMR
Peptides
Sequence alignment

Anmerkungen:

Date Revised 16.07.2022

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/pharmaceutics14051089

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM341539554